Large volume flow electroporation of mRNA: Clinical scale process

Methods in Molecular Biology

Volumn 969, Issue , 2013, Pages 127-138

  Li, Linhong ^a   Allen, Cornell ^a   Shivakumar, Rama ^a   Peshwa, Madhusudan V ^a  

^a MAXCYTE INC   (United States)

Author keywords

Chimeric antigen receptor; Flow electroporation; Large volume transfection; MRNA transfection; NK cells; Scalability

Indexed keywords

CD19 ANTIGEN; LYMPHOCYTE ANTIGEN RECEPTOR; MESSENGER RNA; PLASMID VECTOR;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; B LYMPHOCYTE; CHIMERA; CONTROLLED STUDY; ELECTROPORATION; GENETIC TRANSFECTION; GOOD MANUFACTURING PRACTICE; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKEMIA CELL LINE; LYSIS; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; TARGET CELL; ANIMAL; BIOSYNTHESIS; CHEMISTRY; CYTOLOGY; GENETICS; IMMUNOLOGY; METABOLISM; METHODOLOGY; REVIEW;

ANIMALS; ANTIGENS, CD19; ELECTROPORATION; HUMANS; KILLER CELLS, NATURAL; RECEPTORS, ANTIGEN; RNA, MESSENGER; TRANSFECTION;

MLCS; MLOWN;

EID: 84878647061     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-62703-260-5_9     Document Type: Article

References (37)

1. Fischer A, Hacein-Bey-Abina S, Cavazzana-Calvo M (2011) Gene therapy for primary adaptive immune de ficiencies. J Allergy Clin Immunol 127(6):1356-1359
2. Thacker EE, Timares L, Matthews QL (2009) Strategies to overcome host immunity to adenovirus vectors in vaccine development. Expert Rev Vaccines 8(6):761-777
3. Aaronson SA, Martin MA (1970) Transformation of human cells with different forms of SV40 DNA. Virology 42(4):848-856
4. Graham FL, van der Eb AJ (1973) A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52(2):456-467
5. Neumann E, Schaefer-Ridder M, Wang Y, Hofschneider PH (1982) Gene transfer into mouse lyoma cells by electroporation in high electric fields. EMBO J 1(7):841-845
6. Mac Gabhann F, Annex BH, Popel AS (2010) Gene therapy from the perspective of systems biology. Curr Opin Mol Ther 12(5):570-577
7. Jensen MC, Popplewell L, Cooper LJ, DiGiusto D, Kalos M, Ostberg JR, Forman SJ (2010) Antitransgene rejection responses contribute to attenuated persistence of adoptively transferred CD20/CD19-speci fic chimeric antigen receptor redirected T cells in humans. Biol Blood Marrow Transplant 16(9):1245-1256
8. Li LH, Biagi E, Allen C, Shivakumar R, Weiss JM, Feller S, Yvon E, Fratantoni JC, Liu LN (2006) Rapid and ef ficient nonviral gene delivery of CD154 to primary chronic lymphocytic leukemia cells. Cancer Gene Ther 13(2):215-224
9. Golzio M, Rols MP, Teissie J (2004) In vitro and in vivo electric field-mediated permeabilization, gene transfer, and expression. Methods 33(2):126-135
10. Nishikawa M, Huang L (2001) Nonviral vectors in the new millennium: delivery barriers in gene transfer. Hum Gene Ther 12(8):861-870
11. Hui SW, Li LH (2000) In vitro and ex vivo gene delivery to cells by electroporation. Methods Mol Med 37:157-171
12. Xie TD, Sun L, Tsong TY (1990) Study of mechanisms of electric field-induced DNA transfection. I. DNA entry by surface binding and diffusion through membrane pores. Biophys J 58(1):13-19
13. Zimmermann U (1986) Electrical breakdown, electropermeabilization and electrofusion. Rev Physiol Biochem Pharmacol 105:176-256
14. Lai W, Chang CH, Farber DL (2003) Gene transfection and expression in resting and activated murine CD4 T cell subsets. J Immunol Methods 282(1-2):93-102
15. Li LH, McCarthy P, Hui SW (2001) Highef ficiency electrotransfection of human primary hematopoietic stem cells. FASEB J 15(3):586-588
16. Van Tendeloo VF, Willems R, Ponsaerts P, Lenjou M, Nijs G, Vanhove M, Muylaert P, Van Cauwelaert P, Van Broeckhoven C, Van Bockstaele DR, Berneman ZN (2000) Highlevel transgene expression in primary human T lymphocytes and adult bone marrow CD34+ cells via electroporation-mediated gene delivery. Gene Ther 7(16):1431-1437
17. Li LH, Sen A, Murphy SP, Jahreis GP, Fuji H, Hui SW (1999) Apoptosis induced by DNA uptake limits transfection ef ficiency. Exp Cell Res 253(2):541-550
18. Van De Parre TJ, Martinet W, Schrijvers DM, Herman AG, De Meyer GR (2005) mRNA but not plasmid DNA is ef ficiently transfected in murine J774A.1 macrophages. Biochem Biophys Res Commun 327(1):356-360
19. Trompeter HI, Weinhold S, Thiel C, Wernet P, Uhrberg M (2003) Rapid and highly ef ficient gene transfer into natural killer cells by nucleofection. J Immunol Methods 274(1-2):245-256
20. Ebert O, Finke S, Salahi A, Herrmann M, Trojaneck B, Lefterova P, Wagner E, Kircheis R, Huhn D, Schriever F, Schmidt-Wolf IG (1997) Lymphocyte apoptosis: induction by gene transfer techniques. Gene Ther 4(4):296-302
21. Zhao Y, Moon E, Carpenito C, Paulos CM, Liu X, Brennan AL, Chew A, Carroll RG, Scholler J, Levine BL, Albelda SM, June CH (2010) Multiple injections of electroporated autologous T cells expressing a chimeric antigen receptor mediate regression of human disseminated tumor. Cancer Res 70(22):9053-9061
22. Li L, Liu LN, Feller S, Allen C, Shivakumar R, Fratantoni J, Wolfraim LA, Fujisaki H, Campana D, Chopas N, Dzekunov S, Peshwa M (2010) Expression of chimeric antigen receptors in natural killer cells with a regulatory-compliant non-viral method. Cancer Gene Ther 17(3):147-154
23. Rabinovich PM, Komarovskaya ME, Ye ZJ, Imai C, Campana D, Bahceci E, Weissman SM (2006) Synthetic messenger RNA as a tool for gene therapy. Hum Gene Ther 17(10):1027-1035
24. Rabinovich PM, Komarovskaya ME, Wrzesinski SH, Alderman JL, Budak-Alpdogan T, Karpikov A, Guo H, Flavell RA, Cheung NK, Weissman SM, Bahceci E (2009) Chimeric receptor mRNA transfection as a tool to generate antineoplastic lymphocytes. Hum Gene Ther 20(1):51-61
25. Zhao Y, Zheng Z, Cohen CJ, Gattinoni L, Palmer DC, Restifo NP, Rosenberg SA, Morgan RA (2006) High-ef ficiency transfection of primary human and mouse T lymphocytes using RNA electroporation. Mol Ther 13(1):151-159
26. Warren L, Manos PD, Ahfeldt T, Loh YH, Li H, Lau F, Ebina W, Mandal PK, Smith ZD, Meissner A, Daley GQ, Brack AS, Collins JJ, Cowan C, Schlaeger TM, Rossi DJ (2010) Highly ef ficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modi fied mRNA. Cell Stem Cell 7(5):618-630
27. Yakubov E, Rechavi G, Rozenblatt S, Givol D (2010) Reprogramming of human fibroblasts to pluripotent stem cells using mRNA of four transcription factors. Biochem Biophys Res Commun 394(1):189-193
28. Pruitt SK, Boczkowski D, de Rosa N, Haley NR, Morse MA, Tyler DS, Dannull J, Nair S (2011) Enhancement of anti-tumor immunity through local modulation of CTLA-4 and GITR by dendritic cells. Eur J Immunol 41(12):3553-3563
29. Teufel R, Carralot JP, Scheel B, Probst J, Walter S, Jung G, Hoerr I, Rammensee HG, Pascolo S (2005) Human peripheral blood mononuclear cells transfected with messenger RNA stimulate antigen-speci fic cytotoxic T-lymphocytes in vitro. Cell Mol Life Sci 62(15):1755-1762
30. Brentjens RJ, Riviere I, Park JH, Davila ML, Wang X, Stefanski J, Taylor C, Yeh R, Bartido S, Borquez-Ojeda O, Olszewska M, Bernal Y, Pegram H, Przybylowski M, Hollyman D, Usachenko Y, Pirraglia D, Hosey J, Santos E, Halton E, Maslak P, Scheinberg D, Jurcic J, Heaney M, Heller G, Frattini M, Sadelain M (2011) Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias. Blood 118(18):4817-4828
31. Hudecek M, Schmitt TM, Baskar S, Lupo-Stanghellini MT, Nishida T, Yamamoto TN, Bleakley M, Turtle CJ, Chang WC, Greisman HA, Wood B, Maloney DG, Jensen MC, Rader C, Riddell SR (2010) The B-cell tumor-associated antigen ROR1 can be targeted with T cells modi fied to express a ROR1-speci fic chimeric antigen receptor. Blood 116(22):4532-4541
32. Eshhar Z (2008) The T-body approach: redirecting T cells with antibody speci ficity. Handb Exp Pharmacol 181:329-342
33. Imai C, Iwamoto S, Campana D (2005) Genetic modi fication of primary natural killer cells overcomes inhibitory signals and induces speci fic killing of leukemic cells. Blood 106(1):376-383
34. Biagi E, Marin V, Giordano Attianese GM, Dander E, D'Amico G, Biondi A (2007) Chimeric T-cell receptors: new challenges for targeted immunotherapy in hematologic malignancies. Haematologica 92(3):381-388
35. Finney HM, Akbar AN, Lawson AD (2004) Activation of resting human primary T cells with chimeric receptors: costimulation from CD28, inducible costimulator, CD134, and CD137 in series with signals from the TCR zeta chain. J Immunol 172(1):104-113
36. Witting SR, Li LH, Jasti A, Allen C, Cornetta K, Brady J, Shivakumar R, Peshwa MV (2012) Ef ficient large volume lentiviral vector production using flow electroporation. Hum Gene Ther 23(2):243-249
37. Li LH, Shivakumar R, Feller S, Allen C, Weiss JM, Dzekunov S, Singh V, Holaday J, Fratantoni J, Liu LN (2002) Highly ef ficient, large volume flow electroporation. Technol Cancer Res Treat 1(5):341-350